This Sources Sought opportunity was posted on September 16, 2019. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

MEDICAL SYSMEX REAGENTS AND MICROBIOLOGICAL MEDIA PLATES

Closed

DLATSP-19-SS-0005Federal

Submission Closed10/01/2019, 07:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

International

Pralidoxime Chloride/Methyl Sulfate ManufacturingThis subcontract involves the manufacture and supply of Pralidoxime chloride or methyl sulfate in solution or powder form for injection to support prime contractors on Department of National Defence projects. The required product must have a dosage strength of at least 200 mg per container and a minimum shelf-life of 36 months. The selected provider is responsible for conducting stability testing, providing quality assurance certification, and delivering complete treatment courses along with stability reports and product monographs. To be eligible, the manufacturer must hold a Health Canada Notice of Compliance under Division 8 or Division 11 authorization. This global procurement opportunity is managed by the Government of Canada and allows for performance across various international regions. Interested parties must submit their responses by November 10, 2026.

Department of National Defence

POSTED

DEADLINE

SLS Printer Consumables and Maintenance KitsThis subcontract focuses on the provision of specialized consumables and wear-and-tear replacement parts to support prime contractors working on Department of National Defence projects for the Government of Canada. The scope of supply includes engineering-grade thermoplastic powders such as PA 11, PA 12, PP, and TPU, along with critical SLS hardware components including optical cassettes, recoater blades, infrared heaters, sealing foam gaskets, and build chambers. All bulk consumables and spare parts kits are to be delivered to CFB Petawawa. The opportunity was posted on October 20, 2026, with a response deadline of November 2, 2026, falling under NAICS code 325412.

Department of National Defence

POSTED

DEADLINE

Supplier of Red Sealing Compound (NSN 8030015650423)This subcontract involves the supply of red sealing compound, identified by NSN 8030015650423, for prime contractors working under the Defense Logistics Agency. The material must be provided in 10.00 milliliter containers and strictly adhere to the DLA Master List of Technical and Quality Requirements RA001. The supplier is responsible for managing TYPE I (CODE H) shelf-life requirements and ensuring all packaging complies with MIL-STD-2073-1E and MIL-STD-129 standards. Additionally, the contractor must provide all necessary safety documentation, including SDS and HazCom labels in accordance with 29 C.F.R. 1910.1200. The performance of this contract is centered in FPO 09591-0100, with the primary objective being the delivery of packaged sealing compound and its associated safety certifications to the Department of Defense.

Defense Logistics Agency

POSTED

DEADLINE

Active Pharmaceutical Ingredient (API) SupplyThis subcontract for Active Pharmaceutical Ingredient (API) Supply involves the synthesis, purification, and bulk delivery of pharmaceutical-grade Benzocaine and Menthol. The provider supports prime contractors fulfilling requirements for the Department of Defense Medical Supply Chain Pharm FSA, ensuring all raw chemical components meet strict USP and ISO manufacturing standards through the use of HPLC purity testing. The performance of this contract is centered at Fort Campbell, Kentucky, under NAICS code 325412. The solicitation was posted on October 19, 2026, with a response deadline of October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Benzocaine and Menthol Lozenge SupplyThis subcontract involves the manufacture and supply of finished Benzocaine and Menthol lozenges to prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for producing and quality-testing pharmaceutical lozenges within FDA-compliant facilities adhering to Good Manufacturing Practice standards to ensure all delivered quantities meet strict government specifications. Administrative processes for this requirement are managed through the DLA Internet Bid Board System for quote submissions. The performance of the contract is centered at Fort Campbell, and the procurement falls under NAICS code 325412 for pharmaceutical preparation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Moxifloxacin Hydrochloride Tablets (400 MG)This subcontract, managed by the Medical Supply Chain Pharm FSA under the Department of Defense, involves the manufacture and supply of pharmaceutical-grade Moxifloxacin Hydrochloride Tablets (400 MG). The contractor is responsible for providing the antibiotic tablets in 30-count bottles, ensuring all products are sourced or manufactured in accordance with Good Manufacturing Practices and FDA approval and registration requirements. Logistical compliance is critical, as the contract mandates adherence to RP001 DLA Packaging Requirements and the use of climate-controlled storage and transport to maintain product integrity. Performance will take place in FPO 09591, with the primary objective of supporting prime contractors on DLA supply contracts.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Activated Charcoal, SuspensionThis subcontract, issued by the Medical Supply Chain Pharm FSA under the Department of Defense, requires the provision of activated charcoal in suspension form, identified by NSN 6505012828880. The materials must be delivered to the USS Lewis B Puller ESB 3, with all shipments adhering to strict DLA packaging requirements and technical specifications. The contract falls under NAICS code 325412 and is intended for prime contractors supporting DLA supply operations. Resellers are specifically required to comply with the Non-Manufacturer Rule to ensure eligibility. The performance location is designated as FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of 4% Chlorhexidine Gluconate Surgical DetergentThis subcontract involves the supply of FDA-regulated 4% Chlorhexidine Gluconate surgical detergent for prime contractors supporting Department of Defense supply contracts. The provider is responsible for manufacturing or sourcing the chemical compound in strict accordance with NSN 6505-01-101-3759 specifications and DLA Packaging Requirements RP001. To maintain quality and regulatory compliance, the product must be produced in FDA-approved pharmaceutical manufacturing facilities. The contract mandates a total shelf life of 24 months, with a requirement that the detergent possesses at least 21 months of remaining shelf life at the time of delivery. Managed under the Medical Supply Chain Pharm FSA, the performance of this contract is centered in FPO 96660, falling under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bupivacaine and Epinephrine InjectionThis subcontract involves the supply of Bupivacaine and Epinephrine Injection to prime contractors supporting DLA Troop Support medical supply contracts. The provider must deliver end items compliant with NSN 6505-01-189-3973, utilizing pharmaceutical-grade materials and medical-grade packaging. To qualify, the supplier is required to hold all necessary pharmaceutical manufacturing licenses and maintain FDA approval for the specific drug formulation. Managed by the Department of Defense under the Medical Supply Chain Pharm FSA, the contract specifies the delivery of injectable medication quantities as outlined in the award. The performance location is designated as FPO 09591, and the procurement falls under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isoniazid Tablet ManufacturingThis subcontract involves the manufacturing of Isoniazid 300 MG tablets for prime contractors supporting Department of Defense pharmaceutical supply contracts through the Medical Supply Chain Pharm FSA. The manufacturer is responsible for producing tablets that conform to United States Pharmacopeia standards, packaged in bottles of 100 units. To execute this contract, the provider must utilize pharmaceutical grade API, specialized tablet pressing equipment, and a USP-compliant quality control laboratory. Strict regulatory adherence is required, including the maintenance of active FDA registration and continuous USP compliance. The performance of this contract is centered in FPO 09591, with the primary objective of delivering finished pharmaceutical products that meet all specified government quality and safety benchmarks.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Tetrahydrozoline Hydrochloride Ophthalmic Solution SupplierThis subcontract involves the supply of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP (0.05%, 15 ML) to support prime contractors under DLA Troop Support medical supply contracts. The selected provider is responsible for manufacturing or sourcing the pharmaceutical solution in accordance with USP standards, utilizing sterile ophthalmic bottling and packaging. All operations must comply with FDA approval and registration requirements for pharmaceutical manufacturing. The contract is managed by the Department of Defense under the Medical Supply Chain Pharm FSA. Physical deliveries of the ophthalmic solution are to be made to either the prime contractor or the Naval Med Readiness Logistics Command, with the place of performance located in Williamsburg, Virginia.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Tolnaftate Powder, USP 1%, to prime contractors on DLA Troop Support medical supply contracts. The requirement is for 15 bottles of 45 GM powder, identified by NSN 6505014807897, which must strictly adhere to USP 1% standards and the DLA Master List of Technical and Quality Requirements. Eligible providers must possess the necessary pharmaceutical manufacturing and distribution licenses to fulfill the order. The performance of this contract is designated for FPO 09591, with a response deadline set for October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

The Defense Logistics Agency Troop Support Indo-Pacific is conducting market research to identify capable local sources for the procurement and delivery of Class VIII medical supplies, specifically Sysmex reagents and microbiological media plates. These supplies are intended to support the United States Naval Hospital located in Okinawa, Japan. This announcement is a sources sought notice for informational purposes and does not constitute a formal solicitation or a commitment to procure. The government envisions a Firm-Fixed Price Indefinite Delivery, Indefinite Quantity contract consisting of a 12-month base period and one option period, with an estimated value of under 250,000 dollars per period, including shipping and delivery. The applicable NAICS code is 325412 for Pharmaceutical Preparation Manufacturing. Interested parties were requested to submit their responses by September 30, 2019, to assist the government in making acquisition decisions for the next procurement phase.

General Info

Agency

N/A

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

US PACOM ASBBC United States Naval Hospital (USNH) Okinawa Camp Foster, Building 968, 111 Futenma Bara, Ginowan City Okinawa, J, JPN

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedSep 16

Sources Sought

Response DeadlineOct 1

Deadline has passed

Submission Closed

10/01/2019, 07:00:00 AM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyN/A

Contacts2 people available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

Contacts

Evelyn M. JohnsonContract Specialist

contact@example.gov

Gilbert S. MinceyContract Specialist

contact@example.gov

Full Description

This is only a sources sought announcement and not an intent to procure. A solicitation is not available at this time and any requests for a solicitation will not receive a response. The Defense Logistics Agency (DLA) Troop Support Indo-Pacific is conducting a market research to identify local sources capable and interested in fulfilling a requirement for the procurement and delivery of CLASS VIII, Medical supplies in support of United States Naval Hospital (USNH), located in Okinawa, Japan. The responses to this sources sought synopsis will be used to make appropriate acquisition decisions for the next procurement phase. After review of the responses submitted regarding this potential acquisition, a solicitation announcement may be published in Federal Business Opportunities if and when the Government intends to continue with the procurement. The applicable North American Industry Classification System (NAICS) code is 325412; Pharmaceutical Preparation Manufacturing. The United States (U.S.) industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. DLA Troop Support Pacific contemplates a Firm-Fixed Priced Indefinite Delivery, Indefinite Quantity type contract for a base period of 12 months and one option period estimated under $250,000.00 per period; which is inclusive of shipping and delivery. Item Category Category # Line Item Item Description Unit of Measure Unit of Issue Qty MEDICAL 19402 1 TRIAGE DRUG PANEL 25/bx BX 50 MEDICAL 97401915 2 CI-TROL COAGULATION LEVEL 1 1ml x 20 PG 60 MEDICAL 97402015 3 CI-TROL COAGULATION LEVEL 2 1ml x 20 PG 60 MEDICAL 97402112 4 CI-TROL COAGULATION LEVEL 3 1ml x 20 PG 80 MEDICAL 86400112 5 OWRENS VEMAL BUFFER 500ml EA 30 MEDICAL 95411110 6 DADE FIBRINOGEN DETEMINATION 1ml x 10 PG 36 MEDICAL 6438614 7 DADE ACTIN FSL ACTIVATED PTT 2ml x 10 PG 80 MEDICAL 96406313 8 CA CLEAN 1 50ml EA 84 MEDICAL 96406119 9 CA CLEAN II 500ml EA 12 MEDICAL 4437111 10 D-DIMER NEO R1.5ml x 2 bottle R2.5ml x 2 bottle PG 60 MEDICAL AT967199 11 LIASAUTO DILUENT 38ml PG 48 MEDICAL 95410017 12 DADE PT INNOVINE 10ml x 10 PG 80 MEDICAL 98403016 13 CALCIUM CHLORIDE 15ml x 6 PG 36 MEDICAL AQ793447 14 LIASAUTO CONTROL 38ml PG 60 MEDICAL 42411608 15 Sample Cup 4ml PG 24 MEDICAL 32100025 16 ETHYL ALCOHOL 500 x 20 BX 60 MEDICAL ^04438516 17 D-DIMER STANDARD 1ml x 6 BT PG 5 MEDICAL 98406012 18 STANDARD PLASMA 1ml x 6 BT PG 5 MEDICAL 21219 19 VITEL PIPETTER 346pcs PG 12 MEDICAL 17564 20 0.45% SODIUM SALINE SOLUTION 1000ml BT 15 MEDICAL 17574 21 VITEK II Sterile Tubes 1000/cs BT 20 MEDICAL 417820 22 STERILIZED NACL SOLUTION 1000ml BT 1 MEDICAL 21346 23 NF REF 3.31oz x 20 PG 5 MEDICAL 21342 24 GP REF 0.494oz x 20 PG 40 MEDICAL 21341 25 GN REF 8ml x 20 PG 70 MEDICAL 421040 26 AST-ST03 0.635oz x 20 PG 10 MEDICAL ^031911 27 MEN TIPS 1A1504 300pcs BX 2 MEDICAL 221567 28 BBL Thayer-Martin Modified Agar 10mm x 20 BX 12 MEDICAL 221787 29 BBL Thioglycollate Medium, Enriched with FFP (K1.H Chiogricorate media) 8ml x 10 BX 24 MEDICAL 251169 30 BBL Chocolate II Agar 10mm x 20 BX 72 MEDICAL 252484 31 BBL Anaero Columbia Agar with Rabbit Blood 10mm x 10 BX 24 MEDICAL 252300 32 BBL Salmonella Shigella Agar 100gm x 20 BX 24 MEDICAL 252109 33 BBL BHI Agar Prepared Plates 10mm x 20 BX 12 MEDICAL 221715 34 BBL Trypticase Soy Broth(tube media) 5ml x 10 BX 12 MEDICAL 251727 35 BBL Campylobacter Agar (with 5 Antimicrobics and 10% Sheep Blood(Blaser) Prepared Plates)) 20/bx BX 24 MEDICAL 251361 36 BBL CHROM AGAR O157 10mm x 20 CS 12 MEDICAL 252124 37 BBL OPA II/MSA Biplate 10mm x 20 CS 36 MEDICAL 252020 38 BBL XLD agar Prepared Plate 10mm x 20 BX 24 MEDICAL 251176 39 BBL Muller Hinton Agar with 5% Sheep Blood 10mm x 20 BX 6 MEDICAL 251143 40 BBL TCBS Agar 10mm x 20 BX 6 MEDICAL 251177 41 BBL Muller Hinton II Agar Prepared Plate 100mm x 20 BX 6 MEDICAL 13801836 42 Wako Methanol 500ML GC 95%+ 500ml BT 2 MEDICAL 251172 43 BBL MacConkey II Agar 10mm x 20 PG 504 MEDICAL 251239 44 BBL Trypticase Soy Agar with 5% Sheep Blood 10mm x 20 PG 864 MEDICAL 252355 45 5% Sheep Blood Agar medium supplemented with CA 20/pg PG 12 THIS SOURCES SOUGHT ANNOUNCEMENT IS FOR INFORMATIONAL AND MARKET RESEARCH PURPOSES ONLY. THIS NOTICE DOES NOT CONSTITUTE A SOLICITATION AND SHALL NOT BE CONSTRUED AS A COMMITMENT BY THE U.S. GOVERNMENT. THE U.S. GOVERNMENT IS UNDER NO OBLIGATION TO AWARD A CONTRACT AS A RESULT OF THIS ANNOUNCEMENT. ALL INFORMATION SUBMITTED IN RESPONSE TO THIS ANNOUNCEMENT IS VOLUNTARY The Government will not pay for any materials furnished in response to this notice. Submittals furnished will not be returned to the sender. Responses must be received no later than 10:00 p.m. Hawaii Standard Time (HST) on Monday, 30 September 2019. Please submit all information via email to evelyn.1.johnson@dla.mil and gilbert.mincey@dla.mil

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS